- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Mutual Pharmaceutical Company, Inc.
Total 112 results
-
Tetraphase Pharmaceuticals, Inc.CompletedComplicated Intra-abdominal InfectionUnited States, Latvia, Lithuania, Romania, India, Bulgaria
-
Tetraphase Pharmaceuticals, Inc.CompletedComplicated Appendicitis | Complicated Intra-abdominal InfectionsUkraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Lithuania, Hungary, Latvia, Georgia, Czechia
-
Tetraphase Pharmaceuticals, Inc.Completed
-
Nastech Pharmaceutical Company, Inc.Completed
-
Nastech Pharmaceutical Company, Inc.CompletedDiabetes MellitusUnited States
-
Nastech Pharmaceutical Company, Inc.Withdrawn
-
COUR Pharmaceutical Development Company, Inc.RecruitingMyasthenia Gravis | Generalized Myasthenia | AChR Myasthenia Gravis | MuSK MGUnited States
-
COUR Pharmaceutical Development Company, Inc.Terminated
-
COUR Pharmaceutical Development Company, Inc.Terminated
-
COUR Pharmaceutical Development Company, Inc.Active, not recruitingPrimary Biliary CholangitisUnited States
-
Tetraphase Pharmaceuticals, Inc.PRA Health SciencesCompletedHealthy SubjectsUnited Kingdom
-
TakedaCOUR Pharmaceutical Development Company, Inc.CompletedCeliac DiseaseUnited States
-
TakedaCOUR Pharmaceuticals Development Company, Inc.CompletedStudy of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac DiseaseCeliac DiseaseUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingPrimary Hyperoxaluria Type 3United States, Germany, United Kingdom, Canada, Poland
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyAvailablePrimary Hyperoxaluria Type 1 (PH1)
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingSolid Tumor, Adult | Refractory TumorUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden
-
Tetraphase Pharmaceuticals, Inc.Department of Health and Human ServicesCompletedNormal Drug ToleranceUnited States
-
Alexion Pharmaceuticals, Inc.Eidos Therapeutics, a BridgeBio companyActive, not recruitingSymptomatic Transthyretin Amyloid CardiomyopathyJapan
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Tetraphase Pharmaceuticals, Inc.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Northwestern UniversityGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.Completed
-
Eli Lilly and CompanyAlgorithme Pharma Inc; CoLucid PharmaceuticalsCompletedMigraineUnited States, Canada
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.Terminated
-
Kowa Research Institute, Inc.Eli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedDyslipidemiaUnited States
-
The Emmes Company, LLCBoston Children's Hospital; Ionis Pharmaceuticals, Inc.CompletedAngelman SyndromeUnited States
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.CompletedKidney TransplantationUnited States
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Eli Lilly and CompanyCoLucid Pharmaceuticals; SNBL Clinical Pharmacology Center, Inc.Completed
-
Gangnam Severance HospitalYonsei University; Myung In Pharmaceutical CompanyCompletedCerebral InfarctionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)Technical Resources International, Inc.; Promentis Pharmaceuticals, Inc.; Altasciences...Not yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Guangzhou Lupeng Pharmaceutical Company LTD.; Newave Pharmaceutical IncRecruitingChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaChina
-
Baylor College of MedicineEli Lilly and Company; TAP Pharmaceutical Products Inc.TerminatedHypothyroidismUnited States
-
Eli Lilly and CompanyAlgorithme Pharma Inc; CoLucid Pharmaceuticals; Cognitive Research CorporationCompleted
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
AcelRx Pharmaceuticals, Inc.U.S. Army Medical Research and Development CommandCompletedModerate-to-severe Acute PainUnited States
-
University of Kansas Medical CenterEli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedHypercholesterolemiaUnited States
-
University of Michigan Rogel Cancer CenterGenzyme, a Sanofi Company; Otsuka Pharmaceutical Development & Commercialization...CompletedAcute Myeloblastic LeukemiaUnited States, Canada
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve Inc; MEDPHASE CLINICAL RESEARCH CONSULTANT... and other collaboratorsActive, not recruitingAnemia | Chronic Kidney Disease Requiring Chronic DialysisVietnam
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Genzyme, a Sanofi Company; Millennium Pharmaceuticals...CompletedMultiple MyelomaUnited States
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; Clinical Research Consultants, Inc.; Clinical Research...Active, not recruiting
-
Syneos HealthBristol-Myers Squibb; Merck Sharp & Dohme LLC; AbbVie; Gilead Sciences; Janssen Scientific... and other collaboratorsRecruiting